PHEO tumor biopsies from patients having 123I-mIBG-positive or 123I-mIBG-negative (lack of) uptake were analyzed by immunoblotting to determine the expression levels of NET and DAT (Fig. 1A). The gene discussed is SLC6A2; the disease is neoplasm.